RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
  Avian Influenza
  Cholera
  Hemorrhagic Fevers
  Poliomyelitis
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Avian Influenza Channel

subscribe to Avian Influenza newsletter
Medical News : Epidemics : Avian Influenza

   EMAIL   |   PRINT
WHO welcomes prospect of oseltamivir production in India and Thailand

Oct 20, 2005 - 11:05:00 PM
“The Avian influenza situation is evolving rapidly .Our concern is to protect the world against the threat of an influenza pandemic. Stockpiling of the influenza drug, oseltamivir (Tamiflu), currently the only known drug to show some effectiveness against the H5N1 virus is an important defence against a flu pandemic. Therefore, enhancing availability of and access to antivirals such as oseltamivir is a critical issue,” said Dr Samlee Plianbangchang, Regional Director, WHO’s South-East Asia Region. He added, “We welcome the prospect of regional manufacture of oseltamivir in India and Thailand and also the press statements by Roche regarding its willingness to sub-licence the production to other manufacturers. With this step, a vastly greater amount of oseltamivir would become available which will significantly increase the preparedness. Thus the pharmaceutical industry in the developed and developing world would cooperate in the defence against a public health crisis in the developing world”.

 
[RxPG] “The Avian influenza situation is evolving rapidly .Our concern is to protect the world against the threat of an influenza pandemic. Stockpiling of the influenza drug, oseltamivir (Tamiflu), currently the only known drug to show some effectiveness against the H5N1 virus is an important defence against a flu pandemic. Therefore, enhancing availability of and access to antivirals such as oseltamivir is a critical issue,” said Dr Samlee Plianbangchang, Regional Director, WHO’s South-East Asia Region. He added, “We welcome the prospect of regional manufacture of oseltamivir in India and Thailand and also the press statements by Roche regarding its willingness to sub-licence the production to other manufacturers. With this step, a vastly greater amount of oseltamivir would become available which will significantly increase the preparedness. Thus the pharmaceutical industry in the developed and developing world would cooperate in the defence against a public health crisis in the developing world”.

With avian influenza being reported in birds in European countries, the concern about the pandemic flagged earlier by WHO and other health experts has once again gained global attention. Given the global threat of avian influenza, concerns are being voiced worldwide about the unavailability of sufficient quantities of anti-viral drugs.

While no human cases have been reported from Europe, countries of the South-Asian Region, face the biggest risk of an avian influenza pandemic. Indonesia, Thailand, Cambodia and Vietnam have already reported 117 human cases of avian influenza. Of these 60 people have died, and millions of birds have been culled in an attempt to prevent further spread of the disease. “With every fresh outbreak of H5N1 in birds, the pool of virus circulating in these countries has increased, adding to the risk of infecting more human beings, and perhaps increasing possibility of emergence of a pandemic virus,” said Dr Samlee.

When the pandemic strikes, it would rapidly move around the globe and each country would essentially need to be prepared to deal with its social and economic consequences, nationally.

WHO in the South-East Asia Region is supporting its Member Countries in formulating their national integrated influenza pandemic preparedness plans. Stockpiling of the anti viral drug, which would help to contain the spread the epidemic when it strikes, is one of the important components of the preparedness plan.

Country preparedness plans must include heightened influenza surveillance among human beings and birds, as early signs of disease and death would alert health authorities to take urgent action. Prompt, effective poultry outbreak containment, laboratory support, risk communication and strengthening capacity of human resources are other important response measures.

The avian influenza is a serious potential threat to human health and WHO is working with all its partners to prepare to contain its spread, and to treat those who are infected.



Publication: WHO Regional Office for South-East Asia
On the web: WHO/SEARO 

Advertise in this space for $10 per month. Contact us today.


Related Avian Influenza News
Promising Flu Vaccine from Insects
Bird flu claims eighth victim in Egypt
Seoul reports second bird-flu outbreak in two weeks
Are Flu Vaccines Worth the Effort?
Lessons from SARS may help prepare for bird flu
Incomplete vaccination could worsen the spread of avian flu
Scientists aim to thwart use of flu as bioweapon
Pakistani poultry industry demands 10-year tax holiday
Pandemic prevention plan approved for Asia Pacific
H5N1 threat puts human flu back in spotlight

Subscribe to Avian Influenza Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)